Agenda: Meeting 3. Identifying and Preventing Medication Errors
Day 1, July 6 OPEN SESSION
7:55am-8:00am
Welcome and Introductions
Lyle Bootman, Linda Cronenwett
8:00am-9:45am
Industry Panel Discussion
•Pharmaceutical Industry Representative
Mike Kafrissen, Johnson & Johnson
•Medical Device Industry Representative (Smart Pumps [IVs] and Patient Controlled Analgesia Machines)
Tim Vanderveen, Alaris/Cardinal Health
•Knowledge Base/Pharmacy Database Industry Representative
Jerry Osheroff, Thomson Micromedex
•E-prescribing Technology Representative
Jonathan Teich, Healthvision
9:45am-10:50am
Other Stakeholders Panel Discussion
•PBM Representative
Ed Weisbart, Express Scripts
•Community Pharmacy Representative
Stephen Schondelmeyer, University of Minnesota
•Representative for Over-the-Counter Products
Douglas Bierer, Consumer Healthcare Products Association
10:50am-11:05am
Break
11:05am-12:30pm
Legal Issues Panel Discussion
•HIPAA Expert
Bill Braithwaite, eHealth Initiative
•Peer Review Protection Expert
Luke Sato, Harvard Risk Management Foundation
•State Medical Board Representative
Lisa Robin, Federation of State Medical Boards
•State Pharmacy Board Representative
Carmen Catizone, National Association of Boards of Pharmacy
•State Nursing Board Representative
Vickie Sheets, National Council of State Boards of Nursing
CLOSED SESSION—COMMITTEE ONLY
12:30pm-1:15pm
Lunch
1:15pm-4:55pm
Committee discussions
OPEN SESSION
4:55pm-5:55pm
Open Testimony
6:00pm
Adjournment
Day 2, July 7 OPEN SESSION
7:50am-8:00am
Plan for Day 2, Lyle Bootman, Linda Cronenwett
8:00am-9:00am
Centers for Medicare and Medicaid
•Medicare Modernization Act, Part D
Karen Bell
•Quality Improvement Group
David Hunt
9:00am-10:15am
Federal Legislative Representatives
•Drug Safety and Medication Management Initiatives
Senate Finance Committee
Mark Hayes, Office of Senator Chuck Grassley (R)
•Patient Safety, Quality Improvement, and Health Information Technology Initiatives
Senate Health, Education, Labor, and Pensions Committee
Stephen Northrup, Office of Senator Mike Enzi (R)
David Bowen, Office of Senator Edward Kennedy (D)
10:15am-10:30am
Break
10:30am-12:30pm Government Regulatory Panel Discussion
•FDA-CDER—Drug Safety
Paul Seligman and Carol Holquist
•FDA-CDER—Drug Marketing, Advertising, & Communications
Tom Abrams
•FDA-CDER—New Drugs
John Jenkins
•FDA-CDER—Pediatric Therapeutics
Dianne Murphy
•FDA-CBER—Biologics
Robert Ball
•CDC-ER Surveillance System and Outcomes Research
Dan Budnitz
CLOSED SESSION—COMMITTEE ONLY
12:30pm-1:15pm
Lunch
1:15pm-5:30pm
Committee discussion
5:30pm
Adjournment
Day 3, July 8 CLOSED MEETING—COMMITTEE ONLY
9:00am-12:15pm
Committee discussion
12:15pm-1:00pm
Lunch
1:00pm-2:00pm
Committee discussion
2:00pm
Adjournment
Back to Meeting